An enzyme-linked oligosorbent assay (ELOSA) was developed for the detection on microtiter plates of polymerase chain reaction (PCR)-amplified human immunodeficiency virus type 1 (HIV-1) DNA. The denatured PCR product was hybridized with a passively adsorbed oligonucleotide capture probe and a horseradish peroxidase-labeled oligonucleotide detection probe. The sensitivity and specificity of the PCR-ELOSA technique depended to some extent on the nucleotide sequences of the oligonucleotide primer and probe quartet used in the amplification and detection. We evaluated five oligonucleotide quartets located in the gag, pol, vpr, env, and nef regions of HIV-1. DNAs from 39 HIV-1-seropositive individuals and 27 healthy HIV-1-seronegative controls were amplified by the PCR procedure, and the products were detected by ELOSA.
detection of viral and bacterial DNAs or RNAs in most routine laboratories.
The routine diagnostic procedures used to identify individuals infected with human immunodeficiency virus type 1 (HIV-1) rely on the testing of blood products for antibodies against viral HIV-1 antigens. However, direct identification of the virus is required in several circumstances, such as in children born to HIV-1-seropositive mothers (23) , primary infections before the appearance of antibodies (25) , and monitoring of treatment for HIV-1 infection (2) . Alternative approaches based on the identification of circulating antigen lack sensitivity, and isolation of the virus by cocultivation is time-consuming and requires laboratory facilities.
It has been shown that the sensitive detection of HIV-1 nucleic acids by polymerase chain reaction (PCR) amplification (34) of conserved sequences of HIV-1 proviral DNA is of interest for the diagnosis of HIV-1 infection (11, 23-25, 40) and could be a potential parameter for clinical status (9) or treatment evaluation (2) . The variability of the viral genome, which can lead to problems of specificity and sensitivity, has encouraged many groups to develop primer pairs in various conserved regions of the viral genome, generally gag and/or pol (7, 23, 25, 30, 31) , less frequently env and/or the long terminal repeat (7, 30) , or nef or vif (7) .
These PCR assays normally require analysis by Southern blotting (30) , dot blotting (37), restriction mapping (22) , or a second round of amplification with nested primers (1, 35) in order to discriminate the correct PCR product from nonspecifically amplified sequences. These techniques are generally used in specialized laboratories and are not adapted to * Corresponding author.
large-scale screening. Like routine enzyme-linked immunosorbent assays applied to the detection of proteins, there is a need for a simple, rapid, nonisotopic, and sensitive technique for the detection of amplified HIV-1 genomic material. Because the microtiter plate or tube format is well adapted to clinical applications, these formats have been already used for the detection of DNA (39) . With such an assay format, PCR products must be captured on a solid phase, directly or indirectly, and further detected by direct or indirect labeling. Generally, proteins like streptavidin, which are directed against biotinylated PCR products (14, 35) , or antibodies directed against biotin (38) , DNA-binding protein (20, 26, 32, 36) , or antibodies against DNA-DNA or DNA-RNA hybrids (3) (4) (5) 38) either are coated on the plastic to capture the DNA or RNA target or are used as a detection probe. Nagata et al. (29) first described the direct binding of the DNA target onto a microtiter plate. In the nucleic acid-based sandwich system (8, 33) , two nucleic acid probes are used as a capture or a detection probe. They can be either an insert cloned in a vector like m13, phage X, or pBR322 (15, 17, 33) , a PCR product, or a restriction fragment (16) . DNA fragments or PCR products larger than 300 bp can be coated onto a solid phase either covalently (15) or by passive adsorption (13, 17) . Oligo(dT)14 covalently linked to the solid phase was used to capture a poly(A) tail (12, 27) .
We describe a rapid and easy method for the nonradioactive detection on microtiter plates of PCR-amplified nucleic acid sequences from HIV-1. The detection method that we developed is based on sandwich hybridization, in solution and at 37°C, between a single-stranded DNA template and short synthetic oligonucleotides (18-to 27-mer) as capture Location   gag  PCR  ATAATCCACCTATCCCAGTAGGAGAAAT  SK38  1089-1116  PCR  TTTGGTCCTTGTCTTATGTCCAGAATGC  SK39  1176-1203  Capture  ATTAAATAAAATAGTAAG  CG1105  1141-1158  Detection  TATAAAAGATGGATAATCCTGG  DG375   1118-1139   pol  PCR  CATGGGTACCAGCACACAAAGGAATT  AP714  3695-3720  PCR  TCACTAGCCATTGCTCTCCAATTACT  AP715   3823-3848  Capture  TGAACAAGTAGATAAATTAG  CP759  3729-3748  Detection  GGAATCAGIAAAGTACTATT  DP760  3757-3776   env  PCR  CAGGAAGCACTATGGGCGC  AE552  7346- and detection probes. The fixation of the capture oligonucleotides was done by passive adsorption on the surface of the microtiter wells by using phosphate-buffered saline (PBS) containing high salt concentrations. The detection probe was a horseradish peroxidase-labeled oligonucleotide. We evaluated five different oligonucleotide primer pairs and five corresponding probe pairs for the amplification and detection of HIV-1. Primers in the gag (30) , pol (31), env, vpr, and nef regions were chosen; the internal capture and detection probes are defined below. Inosine was substituted for highly significant mutations, either in amplification primers or capture and detection probes. The five primer pairs and the five probe pairs were used for HIV-1 DNA amplification and detection in samples from 25 HIV-1-seronegative patients and 39 HIV-1-seropositive patients. The PCR amplification and enzyme-linked oligosorbent assay (ELOSA) procedures were found to be simple, rapid, specific, and sensitive. DNA extraction and PCR. DNA preparations from 5-ml blood samples were obtained by using an Applied Biosystems 340A nucleic acid extractor. HIV-1 DNA was amplified by PCR by using 1 ,ug of extracted genomic DNA in a 100-,ul volume containing 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 1.5 mM MgCl2, 0.01% gelatin, 200 mM each dATP, dCTP, dGTP, and dTTP, 50 pmol of each primer, and 1.5 U of recombinant Taq polymerase (Perkin-Elmer Cetus). Cycling conditions were denaturation for 1 min at 95°C, annealing for 1 min at 55°C, and extension for 1 min at 72°C for 35 cycles and then a final extension for 7 min at 72°C. The Ras cellular gene was amplified as a control for DNA quality and PCR performance by using the same PCR conditions described above, except that cycling was limited to 25 cycles.
MATERIALS AND METHODS
Primers and probes. All the oligonucleotides (Table 1) were prepared by the phosphoramidite method on an Applied Biosystems 394 synthesizer and were purified by reverse-phase high-pressure liquid chromatography (HPLC). The oligonucleotides used for detection and capture were synthesized with an amine arm at the 5' end. The addition was performed on a synthesizer with the Aminolink II reagent (Applied Biosystems). Horseradish peroxidase labeling of the oligonucleotides used for detection was performed as described by Keller and Manak (18) . Preparation of the oligonucleotide-enzyme conjugate was as follows. A total of 200 ,ug of oligonucleotide synthesized with an Aminolink II arm was dried and mixed with 500 ,ul of 1,4-phenylene diisothiocyanate (Sigma Chemical Co.; 20 mg/ml in dimethylformamide) and 25 ,ul of sodium borate buffer (0.1 M; pH 9.3). The tube was incubated in the dark for 2 h before three extractions with n-butanol. The aqueous phase containing the activated oligonucleotide was dried and mixed with 200 jil of 0.1 M sodium borate (pH 9.3) containing 2 mg of horseradish peroxidase. After one night of incubation at room temperature, the conjugate was purified by ion-exchange HPLC. The labeled detection probe can be stored at -20°C in glycerol for several months. Reproducibility of the ELOSA method. A total of 1 p.g of HIV-1 DNA extracted from patient samples was amplified by PCR with the gag, pol, env, vpr, and nefprimer pairs, and PCR products were analyzed by the ELOSA as described above. Ten independent ELOSA determinations were performed, with each one done in two separate wells.
Sensitivity of the PCR-ELOSA on an in vitro model. A total of 1 p.g of human DNA containing 10 copies of plasmid pBH10 and 1 p.g of human DNA used as a negative control were amplified by PCR with the gag, pol, env, vpr, and nef primer pairs. Five independent PCRs were performed and the PCR products were analyzed by ELOSA as described above.
Statistical analysis. Differences in the ability of the PCR-ELOSA to detect the control cellular gene and the amplified HIV-1 sequences between HIV-1-seronegative controls and HIV-1-seropositive individuals were assessed by the MannWhitney U test. Differences between CDC stages were assessed by the Kruskal-Wallis test. Detection data are displayed graphically in "box-whisker" plots (StatView II; Abacus Concepts, Inc., Berkeley, Calif.): the tops and bottoms of the boxes represent the 75th and 25th percentiles, respectively; the middle 50% of the ODs are contained within the span defined by the box boundaries, and the line inside the box represents the 50th percentile or median; the lines extending above and below the box are referred to as "whiskers"; the top whisker is drawn from the 75th percentile to the 90th percentile; the bottom whisker is drawn from the 25th percentile to the 10th percentile; the values (outliers) under the lower whisker and above the upper whisker represent observed values below and above the 10th and 90th percentiles, respectively. 
RESULTS
Reproducibility of the ELOSA method. Preliminary experiments performed on various biological and synthetic models have shown that no less than between 1/100th (1 ,ul) and 1/25th (4 ,ul) of the PCR mixture is required to detect between 1 and 10 copies of a target gene, depending on the oligonucleotide quartet used, i.e., the primer pairs and subsequent probe pairs (data not shown). Because the aim of the present study was not to quantify the HIV-1 proviral DNA but to detect at least 10 copies in 1 ,ug of total DNA, we chose to use 1/10th of the PCR mixture.
Coefficients of variation of the gag, pol, env, nef, and vpr probe systems ranged from 5.1 to 7.3% for ODs ranging from 311 to 2,041 ( Table 2) .
Sensitivity of the PCR-ELOSA on an in vitro model. By using 10-fold serial dilutions of a PCR which had reached its plateau, preliminary experiments showed that the sensitivity of the ELOSA method was similar to that of overnight autoradiography of Southern blots revealed by a radiolabeled oligonucleotide probe (data not shown). Before testing of the primer and probe quartets on DNAs isolated from patients, we first checked their sensitivities. The results of five independent PCR reactions and ELOSA analyses are plotted in Fig. 1 
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samples from patients at different CDC stages. This was expected, because the method was not meant to be quantitative.
The distributions of the five HIV-1 PCR-ELOSAs and the Ras control PCR-ELOSA (seronegative versus seropositive) determined by the box plot graphic method are presented in Fig. 2 . Analysis of the ability of PCR-ELOSA to detect genes in samples from healthy seronegative controls (hereafter referred as gene negative) between each system showed that the gag-negative box and whiskers were "thicker" than those for the other gene systems (Fig. 2B) , so we can conclude that the gag background is significantly higher, inducing a high OD cutoff (see below). All other systems had "thin" boxes and whiskers (Fig. 2B) , a regular distribution similar to the gag-negative group, except for the env-negative group, which had a relatively high OD value for the sample from one patient (Fig. 2B, lane ENV-) , inducing a dramatic increase in the OD cutoff (see below). Analysis of gene detection by PCR-ELOSA in samples from HIV-1-seropositive patients (hereafter referred as gene positive) between each system was done; because the boxes associated with gag-positive and vpr-positive PCR-ELOSA were thinner than the boxes associated with other gene systems ( Fig. 2A) , we conclude that the middle 50% of the OD distribution from the gag-positive and vpr-positive samples were more homogeneous than those for samples from other systems. Meanwhile, the fact that the whisker associated with the higher gagpositive, vpr-positive, and nef-positive ODs was longer than the whisker associated with the lower OD ( Fig. 2A) suggests a positively skewed distribution. On the contrary, pol-positive and env-positive samples exhibited a symmetric distribution because of the positioning of the median near the middle of the box (Fig. 2A) .
The OD cutoff, which was calculated as the mean negative value plus 3 standard deviations, was estimated for each gene system by using data for the 27 HIV-1-seronegative controls. The respective cutoffs were an OD of 19 for thegag system, an OD of 8 for the pol system, an OD of 30 for the env system, an OD of 8 for the nef system, and an OD of 4 for the vpr system. Specificities of 100% were obtained for the gag, pol, nef, and vpr systems, a specificity of 96% was obtained for the env system. The sensitivity was 97% for the pol system, 95% for the gag, env, and nef systems, and 85% for the vpr system. The specificity and sensitivity of gene detection by PCR-ELOSA were highlighted by comparison of the lower whiskers and outliers (Fig. 2B) for the HIV-1-seropositive patients with the higher whiskers and outliers for the HIV-1-seronegative controls; it shows the nonhomogeneous results obtained for eight individuals, including the previously described HIV-1-seronegative control (patient TA80) with a high env OD value of 44 (Fig. 2B, lane ENV-) , and the significant overlap of vpr-positive and vpr-negative results, including those for six HIV-1-seropositive patients (Fig. 2B, lanes VPR+ and VPR-) ; one of them (patient TS220) was not detected by the gag, pol, nef, and vpr systems but had a low OD value, 42, by the env system. Added to the specificity and sensitivity criteria, the graphic method outlines the proximity of several gagpositive weak signals (<8% of the gag-positive signals were within lx and 2x the cutoff value) with the gag-negative HIV-1-seronegative control. The nef system presented the same results with a lower amplitude (<2% of the nef-positive signals were within lx and 2x the cutoff value). On the contrary, the lower positive pol-positive OD is largely distant from the higher pol-negative OD (>4x cutoff). DISCUSSION PCR-ELOSA is a practical method for measuring the specific DNAs generated by PCR. The procedure combined a sandwich hybridization reaction with a conventional enzyme immunoassay. The denatured DNA template is captured by a specific oligonucleotide probe that is passively adsorbed onto the surface of a microtiter well. The hybridized template is then detected by using a horseradish peroxidase-labeled oligonucleotide probe. By using coated oligonucleotide plates, assays can be completed in less than 2 h. The reliability of the ELOSA method is suitable for use as a clinical assay, with coefficients of variation ranging for all systems from 5.1 to 7.3% for ODs ranging from 311 to 2,041. The PCR-ELOSA method detected at least 10 copies of HIV-1 plasmid DNA in a background of 1 ,ug of total DNA, corresponding to approximately 150,000 cells, with each of the five oligonucleotide primer pairs and probe pairs.
The specificities and sensitivities obtained for thepol, nef, gag, and env systems were very similar to those reported previously (5, 7, 24, 38, 39). The gag, pol, nef, and vpr oligonucleotide quartets described in this report were 100% specific for samples from the 63 patients tested. A disturbing result concerned the env system, whose specificity was 96%. The cutoff was determined to be an OD of 30; if we exclude the data for patient TA80, for whom the OD was 44, the cutoff would be shortened to 5. Because the env system is the only one that gave a significant OD, 42, for the sample from patient TS220, which was not detected by the four other systems, it would be of great interest to test the env system on a larger panel of samples to obtain a more significant cutoff. The sensitivity was 97% for the pol system, 95% for the gag, env, and nef systems, and 85% for the vpr system. A total of 82% of the HIV-1-seropositive patients were detected simultaneously by the five oligonucleotide quartets, and 92% were detected if we exclude the vpr system. Viral diversity could be an explanation for the different sensitivities of the oligonucleotide quartets, especially the low sensitivity of the vpr system; this hypothesis is reinforced by three observations. (i) The seven patients in whom HIV-1 was only partially detected did not belong to a specific CDC stage, excluding an association with clinical status; (ii) the patients' CD4 counts were not particularly low (574 + 202/mm3), and (iii) patient TS220 was of African origin. Several investigators (7, 30) indicated that it is necessary to use multiple primer pairs for the detection of various viral genomes. Using the samples from the 39 HIV-1-seropositive patients, except for the sample from patient TS220, for whom the env system provided an ambiguous result, all results were positive with the pol system. Thus, it would be of interest to test the pol, env, and nef systems on a larger panel of samples, including samples from patients from different geographic areas, patients at risk of HIV-1 infection, and children born to HIV-1-seropositive mothers. Nevertheless, use of different primers and probes may overcome some striking differences in reactivity. These differences, potentially linked to viral variability, could be part of either the PCR step or the detection step, although the length of the oligonucleotides used in those detection systems allowed tolerance to point mutations. Increased sensitivity could be achieved by using two or more capture probes and two or more detection probes. This is more particularly feasible with a system with positive values far above the cutoff value, because of the risk of increasing the background value.
Optimization of the specificity and sensitivity of the PCR-ELOSA for HIV-1 detection could be achieved by using coamplification of several parts of the genome such as the pol and env genes, with the various products generated being detected simultaneously in a single well. Coamplification of one HIV-1 segment with a cellular gene as a reporter gene (19) could also be used as a quantitative approach to determining the viral load in patients, the result being expressed as the ratio of the OD of the HIV-1 gene and the OD of the cellular gene detected by ELOSA.
Furthermore, the ELOSA system has been used to detect, nonisotopically and at a single temperature, point mutations for HLA DR typing (6) by the microtiter plate format. It is also suitable for automation, and typing of human papillomavirus has been defined on the VIDAS (BioMerieux/Vitek) multiparametric immunoanalysis automated analyzer (la) . Furthermore, because ELOSA was able to detect singlestranded DNA and RNA, it either could be used for the direct detection of nucleic acids or could be coupled with amplification systems such as PCR or transcription-based amplification methods (10, 21) . Because the ELOSA method proved to be efficient and practical and because it does not require highly specialized technicians or molecular biology equipment, it has the potential to become a widespread method for the detection of nucleic acids in clinical laboratories.
